Tumor necrosis of lung cancer: detection by Tl-201 and 99mTc-MIBI scinitgraphy
D. P. Sobic-Saranovic, S. Pavlovic, G. Radosavljevic-Asic, N. Kozarevic, D. Jovanovic, V. Obradovic, V. Bosnjakovic (Belgrade, Yugoslavia)
Source: Annual Congress 2002 - Oncology imaging: CT, MRI and PET
Session: Oncology imaging: CT, MRI and PET
Session type: Oral Presentation
Number: 3763
Disease area: Thoracic oncology
Abstract Thallium choride-201 (Tl-201) and technetium-99m hexakis 2-methoxy isobutylisonitrile (99mTc-MIBI) are indicators of tumor viability and they do not accumulate in necrotic tissues. The aim of this study was to evaluate frequency of tumor necrosis in patients with lung cancer by Tl-201 and 99mTc-MIBI scinitgraphy. We studied 44 patients with histollogicaly proven lung cancer divided in two groups: 20 patients in group I (4 pts with small cell lung cancer-SCLC, and 16 pts with non-small cell lung cancer -NSCLC) were injected with 74 MBq of Tl-201, while in Group II 24 patients (5 pts with SCLC and 19 pts with NSCLC) were injected with 370 MBq of 99mTc-MIBI. Thoracic scintigraphy in anterior and posterior projection were acquired in both groups. In case of positive findings, tumor to nontumor (T/NT) ratio was calculated.Results: In Group I 18/20 (90%) patients were found true positive on Tl-201 scinitgraphy, and in 4 of 18 patients (22%) focal uptake with central necrosis was present. In Group II 20/24 (83%) of patients were found true positive on 99mTc-MIBI chest scinitgraphy, while tumor necrosis was found in 5/20 (25%) true positive scinitgrams. No significance differences in mean T/NT ratio between Group I (Tl-201) and Group II (99mTc-MIBI) were detected (1.63 ±] 0.32 vs. 1.61 ±] 0.30,p>0.05, respectively).Conclusion: Our results indicate that primary lung cancer was detected by thoracic scinitgraphy with T-201 and 99mTc-MIBI in 38/44 (86%) patients, and tumor necrosis in 20% (9/44) of them. Both scinitgraphies are noninvasive and effective for the detection of tumor necrosis that may influence the response to treatment of patients with lung cancer.
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. P. Sobic-Saranovic, S. Pavlovic, G. Radosavljevic-Asic, N. Kozarevic, D. Jovanovic, V. Obradovic, V. Bosnjakovic (Belgrade, Yugoslavia). Tumor necrosis of lung cancer: detection by Tl-201 and 99mTc-MIBI scinitgraphy. Eur Respir J 2002; 20: Suppl. 38, 3763
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Significance of Tl-201 and MIBI-99mTc lung scintigraphy in advanced lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 247s Year: 2003
Role of Tc-99m MIBI chest SPECT to detect mediastinal lymph node metastasis in patients with non-small cell lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 314s Year: 2005
Value of Tc-99m-MIBI scintigraphy in predicting the cytostatic responsiveness of the non-small lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 377s Year: 2001
Comparison of CT and PET in detection of lung metastases Source: Annual Congress 2004 - Lung cancer: epidemiology, diagnosis, staging Year: 2004
99m Tc-tetrofosmin (TF) SPECT usefulness in solitary pulmonary nodulesSource: Eur Respir J 2005; 26: Suppl. 49, 212s Year: 2005
Bone and Tl-201 image overlay in detection of musculoskeletal metastases of lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 245s Year: 2003
Synchronous primary malignancies identified during staging 18F-FDG PET scan in lung cancer patients Source: Annual Congress 2010 - Staging of lung cancer Year: 2010
Scintigraphy with 99m Tc-depreotide has a high sensitivity in detecting lung cancer Source: Annual Congress 2007 - Diagnosis and staging of lung cancer: existing and new techniques Year: 2007
Radionuclid 99m Tc – depreotide in the diagnosis of solitary pulmonary nodules Source: Eur Respir J 2003; 22: Suppl. 45, 251s Year: 2003
Radionuclid 99m Tc – depreotide in the diagnosis of solitary pulmonary nodules Source: Eur Respir J 2004; 24: Suppl. 48, 48s Year: 2004
Comparision of FDG PET/CT and bone scanning for bone metastases in operable non-small cell lung cancer Source: Annual Congress 2009 - Management of thoracic malignancies Year: 2009
The use of SPECT in preoperative assessment of patients with lung cancer Source: Eur Respir J 2004; 24: 258-262 Year: 2004
PET/CT of lung cancer Source: International Congress 2018 – PG4 Imaging of the chest Year: 2018
Mediastinoscopy versus CT and PET in preoperative N-staging of lung cancer Source: Annual Congress 2009 - Current challenges in thoracic surgery Year: 2009
Increased FDG uptake on 18F-FDG PET/CT in residual lesions of tuberculosis Source: International Congress 2019 – Tuberculosis: from diagnosis to complications Year: 2019
The role of 99m Tc labelled depreotide scanning in investigating suspected lung cancer - more than just the solitary pulmonary nodule Source: Eur Respir J 2002; 20: Suppl. 38, 458s Year: 2002
The estimation of the relative liver perfusion in metastases of bronchus and lung carcinoma by hepatic radionuclide angiography Source: Eur Respir J 2002; 20: Suppl. 38, 265s Year: 2002
The use of perfusion SPECT imaging for preoperative evaluation of patients with lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 38s Year: 2002
A lung cancer patient with multiple lesions on PET scan Source: Annual Congress 2006 - Clinical Grand Round: an interactive session Year: 2006
Tc-99m depreotide scintigraphy in the evaluation of solitary pulmonary nodule Source: Eur Respir J 2005; 26: Suppl. 49, 312s Year: 2005